Нимотоп S

Nimotop S is an intravenous calcium channel blocker used to prevent vasospasm after subarachnoid hemorrhage. It helps maintain cerebral blood flow during critical care. Nimotop S injection is administered under medical supervision for targeted vascular support. This EU-sourced solution is designed for hospital and clinical environments.

Nimotop S is primarily used to prevent or reduce cerebral vasospasm following a subarachnoid hemorrhage, a type of brain bleed. It works by relaxing blood vessels in the brain to improve circulation. The medication is intended for patients in acute care settings where close monitoring is available. It supports recovery by reducing the risk of secondary complications linked to reduced blood flow.

Nimotop S helps maintain steady blood flow to the brain by relaxing arterial muscles. Patients may experience improved oxygen delivery to brain tissues during treatment. The medication is designed to act selectively on cerebral blood vessels, minimizing widespread effects. Its effects are typically observed within hours of administration.

Nimotop S should only be handled and administered by healthcare professionals in controlled settings. Patients with severe hypotension or unstable blood pressure require careful monitoring during infusion. The solution must be used as directed and stored according to manufacturer guidelines. Always check compatibility with other intravenous medications before administration.

Nimotop S may interact with other drugs that affect blood pressure, such as antihypertensives or vasodilators. Caution is advised when combining with CYP3A4 inhibitors, which can increase nimodipine levels. Alcohol and grapefruit products may also influence its effects. Always inform healthcare providers of all medications being used.